Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016
Wee Loon Ong, Sue M Evans, Melanie Evans, Mark Tacey, Lachlan Dodds, Paul Kearns, Roger L Milne, Farshad Foroudi, Jeremy Millar
European Urology Oncology | ELSEVIER | Published : 2021
Conservative management, specifically with active surveillance (AS), has emerged as the preferred approach for low-risk prostate cancer (LRPC). We evaluated the trend for conservative management (ie, no active treatment within 12mo of diagnosis) for LRPC in an Australian population-based cohort of men captured in the Prostate Cancer Outcomes Registry Victoria (PCOR-Vic). Of the 3201 men diagnosed with LRPC between January 2009 and December 2016, 60% (1928/3201) had conservative management, and 52% (1664/3201) were documented to be on AS. There was an increase in conservative management from 52% in 2009 to 73% in 2016 (p<0.001), largely attributable to an increase in AS from 33% in 2009 to 67..View full abstract
This work was supported the Movember Foundation, which played a role in data collection and management.